Euphorbia jolkinii

Euphorbia jolkinii · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Euphorbia jolkinii is a medicinal plant known for the potent therapeutic potential found within its root. Scientific research has focused on utilizing various preparations, including crude extracts, hot-water extracts, and specific root extracts, to harness its bioactive compounds. These extracts have shown significant promise in addressing complex health conditions such as Candida albicans and Herpes Zoster. Furthermore, studies suggest the plant may play a role in managing severe pathologies like Leukemias and Liver Cirrhosis. Understanding the medicinal properties of this species offers valuable insights into its diverse pharmacological applications.

Quick facts
Synonyms
Euphorbia Calonesiaca · Galarhoeus Formosanus · 18 more
Common names
Not available
Family
Euphorbiaceae
Distribution
Northern America
Plant Parts
Root

Classification

Common Names

Euphorbia jolkinii is a fascinating plant known by several distinct common names across different regions. In certain areas, it is affectionately referred to as イワタイゲキ or タイワンタカトウダイ. It also holds the traditional name 八卦草, reflecting its cultural significance. Depending on local usage, you may encounter it labeled as 台灣大戟 or simply as 大甲草. These diverse names highlight the wide-ranging linguistic identity of this unique species.

Sources: Catalogue of Life (COL)

Synonyms

Euphorbia jolkinii is a botanical subject characterized by a complex web of taxonomic synonyms. This plant is frequently identified in scientific literature under various alternative names, such as Dichrophyllum jolkinii and Euphorbia calonesiaca. Additionally, its classification encompasses several other designations, including Euphorbia formosana and the specific form Euphorbia jolkinii f. insularis. Researchers may also encounter it referred to as Euphorbia nematocypha depending on the historical context of the study. Understanding these diverse nomenclature relationships is essential for accurate identification within the genus.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Euphorbia jolkinii is a fascinating member of the kingdom Plantae. Within this vast biological realm, the species belongs to the class Equisetopsida. It is further categorized under the order Malpighiales, which connects it to a diverse range of other flowering plants. This specific plant is a prominent representative of the genus Euphorbia. Finally, it finds its taxonomic home within the expansive Euphorbiaceae family.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Malpighiales
Family Euphorbiaceae
Genus Euphorbia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Euphorbia jolkinii is a resilient species widely distributed throughout the temperate regions of Asia. Its natural habitat spans a broad geographical range, beginning with significant populations in China and its south-central provinces. The plant is also commonly found across Eastern Asia, establishing a presence in both Japan and the Korean Peninsula. Furthermore, its reach extends to the Nansei-shoto islands and the island of Taiwan. This widespread distribution highlights the plant's ability to thrive in various temperate environments across the continent.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Euphorbia jolkinii grows in a classic herb form, characterized by its soft, non-woody tissues. This plant is entirely self-supporting, allowing it to maintain its structure and posture without the need for external assistance.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Euphorbia jolkinii is a plant species notable for its specific chemical profile. Detailed analysis reveals that this species contains several significant bioactive compounds. Specifically, the plant is found to contain brevifolin, which contributes to its unique chemical makeup. In addition to this, it contains hyperin and ellagic acid. These constituent elements highlight the complex phytochemical properties inherent to the plant.

Conditions

Euphorbia jolkinii demonstrates significant therapeutic potential, specifically in its ability to treat DU145 human prostate cancer cells by inducing apoptosis. This plant also serves as an effective agent to treat prostate cancer through various signaling pathways. Beyond its oncological benefits, it exhibits antihepatotoxic activity that helps protect against liver damage. Furthermore, the plant shows medicinal value in its ability to treat Candida albicans. Finally, Euphorbia jolkinii is utilized to treat herpes zoster, contributing to its diverse range of health applications.

Preparations

Euphorbia jolkinii is prepared as a crude extract to investigate its cytotoxic effects on human cancer cells. This plant is also prepared as a hot-water extract, which has shown the ability to selectively inhibit the growth of leukemic cancer cells. Additionally, Euphorbia jolkinii is prepared as a root extract to study its role in inducing apoptosis via specific cellular pathways. These various preparation methods, including the use of crude, hot-water, and root extracts, are essential for exploring the plant's medicinal potential. Each form of the extract serves a specific purpose in determining how the plant interacts with different cancer cell lines.

Parts used

Euphorbia jolkinii is a plant species that contains a specific part known as the root. Research into related species, such as Euphorbia formosana, has highlighted the significant medicinal potential found within these root extracts. Specifically, studies show that extracts from such plants can induce apoptosis in human leukemic cells through both Fas and mitochondrial pathways. This selective inhibition of cancer cell growth offers a promising avenue for developing new therapies for acute myeloid leukemia. Ultimately, the bioactive properties found in the roots of the Euphorbia genus warrant much deeper investigation for clinical applications.